Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

Mar 22, 2023 · Cognito Therapeutics raised $73000000 on 2023-03-22 in Series B

CouponFollow Extension

$73000000
OFF

Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase

1 week from now

Mar 22, 2023 · Cognito Therapeutics raised $73000000 on 2023-03-22 in Series B

crunchbase.com

$73
OFF

Cognito Therapeutics Scores $73m Series B - Venture Capital Journal

1 week from now

Mar 22, 2023 · Cambridge, Massachusetts-based Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, has raised $73 million …

venturecapitaljournal.com

$73
OFF

Firm Advises Cognito Therapeutics On $73 Million Series B Financing

1 week from now

Mar 31, 2023 · On March 22, 2023, neurotechnology company Cognito Therapeutics announced a $73 million Series B financing round. The financing was led by FoundersX Ventures with …

wsgr.com

$73000000
OFF

Founder Lodge | Cognito Therapeutics, Inc. Raises $73,000,000 At …

1 week from now

Mar 23, 2023 · Cognito Therapeutics, Inc. raises $73,000,000 at Series B on 2023-03-23 in Medical Equipment Manufacturing, industry founded/co-founded by Brent Vaughan. Daily …

founderlodge.com

$35
OFF

Cognito Therapeutics Raises $35M Series B Extension

1 week from now

Jan 30, 2024 · Funding August 22, 2024. Clinical Trials. ... Cognito Therapeutics raises $35M Series B extension. January 30, 2024. 110. Linkedin. ... The round is an extension of the …

gsmedtech.com

$227
OFF

Cognito Therapeutics - Raised $227M Funding From 6 Investors

1 week from now

Oct 29, 2024 · Cognito Therapeutics has raised a total funding of $227M over 5 rounds from 6 investors. Investors include Morningside, FoundersX Ventures and 4 others. ... Alzheimer's …

tracxn.com

$35
OFF

Cognito Raises $35M, Launches Alzheimer’s Biomarker Study

1 week from now

Feb 1, 2024 · Cognito Therapeutics Inc. closed a $35 million extension to the series B fundraising round it started in 2023, bringing the total for the round to $108 million and the total funding to …

bioworld.com

$35
OFF

Cognito Therapeutics Raises $35M Series B Extension - VatorNews

1 week from now

Cognito Therapeutics raises $35M Series B extension . The company raised a $73 million round in March of 2023 by Steven Loeb on January 29, 2024 ... October 03, 2024 Online brand …

vator.tv

$35000000
OFF

Series B - Cognito Therapeutics - 2024-01-29 - Crunchbase

1 week from now

Jan 29, 2024 · Cognito Therapeutics raised $35000000 on 2024-01-29 in Series B

crunchbase.com

$123000000
OFF

Series B - Flare Therapeutics - 2023-03-22 - Crunchbase

1 week from now

Mar 22, 2023 · Flare Therapeutics raised $123000000 on 2023-03-22 in Series B

crunchbase.com

FAQs about Series B - Cognito Therapeutics - 2023-03-22 - Crunchbase Coupon?

Does Cognito therapeutics have a series B financing?

CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Cognito Therapeutics, a neurotechnology company advancing disease-modifying therapies to treat CNS diseases, announced today a $73M Series B financing round led by FoundersX Ventures with participation from all existing investors. ...

Who is Cognito Therapeutics?

About Cognito Therapeutics Cognito Therapeutics is a clinical-stage neurotechnology company developing disease-modifying therapeutic approaches to treat neurodegenerative disorders. Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. ...

Who will join Cognito's Board of directors?

In addition to the financing, Dr. Rick Kuntz, MD, MSc, former Senior Vice President, Chief Medical and Scientific Officer of Medtronic and Helen Liang, Founder & Managing Partner at FoundersX, will join Cognito’s Board of Directors. Dr. ...

Is Cognito a non-invasive neuromodulation device?

Its non-invasive neuromodulation platform was developed by MIT Professors and scientific founders Li-Huei Tsai and Ed Boyden. The Company’s lead therapy is currently in a pivotal study in Alzheimer’s Disease and was awarded FDA Breakthrough Device Designation. Cognito is based in Cambridge, MA. ...